Reproductive health conditions over the life-cycle, such as those related to adolescence, childbearing, sexual activity, and aging, represent a significant burden of disease on a global scale;contributing extensively to morbidity and disability in low and middle-income countries. Reproductive health extends before and beyond the years of reproduction, and is closely associated with socio-cultural factors, gender roles and the respect and protection of human rights, especially - but not only- in regard to sexuality and personal relationships. The current proposal is for a planning grant to develop a consensus and a detailed different levels of multidisciplinary reproductive health training programto provide concepts, knowledge and skills from a variety of disciplines to support the best practice of health workers, researchers and other stakeholders relating to reproductive health globally. Such training will effect the integration of a global perspective into health services and policy making, both within China and internationally.
The specific aims of this planning grant are: 1. To identify and solicit multidisciplinary expertise to form an advisory board, which will meet to direct and support the design of a global reproductive health training program at Fudan University;2. To form a multidisciplinary working group for curricula development;3.To identify and solicit partners (international academic institutions and NGOs) with strength and expertise in education, clinical practice, reproductive health research, and psycho-social-behavioral science, to form a collaborative teaching network;4. To pilot new curricula through current continuing medical education programs at Fudan University and other venues;5.To assesstraining needs and identify priorities for a global RH training program;6. To develop a Phase II training grant application for submission to NIH Fogarty /Framework Programs for Global Health. The planning work will be implemented by the steering committee which consist of the PI, the program coordinator, and key investigators from our partner institutions sepicalized in educaion, clinical practice and scientific researchers. International consultants will help in educational program design and support the curricula develop as well as teaching network estabishment. Priority identification will be based on needs and resources assessment. The new curricula will be piloted through current educational programs.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
3R01HL078726-04S1
Application #
7837466
Study Section
Hemostasis and Thrombosis Study Section (HT)
Program Officer
Kindzelski, Andrei L
Project Start
2009-07-01
Project End
2011-06-30
Budget Start
2009-07-01
Budget End
2011-06-30
Support Year
4
Fiscal Year
2009
Total Cost
$170,374
Indirect Cost
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Dentistry
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Cho, Michael Jeffrey; Lo, Agnes S Y; Mao, Xuming et al. (2014) Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients. Nat Commun 5:4167
Litvinov, Rustem I; Yarovoi, Serge V; Rauova, Lubica et al. (2013) Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4. J Biol Chem 288:33060-70
Cuker, Adam; Rux, Ann H; Hinds, Jillian L et al. (2013) Novel diagnostic assays for heparin-induced thrombocytopenia. Blood 121:3727-32
Sachais, Bruce S; Litvinov, Rustem I; Yarovoi, Serge V et al. (2012) Dynamic antibody-binding properties in the pathogenesis of HIT. Blood 120:1137-42
Sachais, Bruce S; Rux, Ann H; Cines, Douglas B et al. (2012) Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopenia. Blood 119:5955-62
Tanhehco, Yvette C; Rux, Ann H; Sachais, Bruce S (2011) Low-density lipoprotein apheresis reduces platelet factor 4 on the surface of platelets: a possible protective mechanism against heparin-induced thrombocytopenia and thrombosis. Transfusion 51:1022-9
Sachais, Bruce S; Turrentine, Tiffany; Dawicki McKenna, Jennine M et al. (2007) Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice. Thromb Haemost 98:1108-13